Takeda (TSE:4502/NYSE:TAK) focuses on creating better health for people and a brighter future for the world. It aims to discover and deliver life-transforming treatments in core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. With its partners, Takeda aims to improve the patient experience and advance a new frontier of treatment options through a dynamic and diverse pipeline. Headquartered in Japan, the company has a commitment to patients, people and the planet. Takeda has employees in approximately 80 countries and regions.
Value-based healthcare prioritizing patient outcomes is a solution to current over-burdened health systems – but it means handling data better and more responsibly.
Global warming is helping mosquitoes to spread mosquito-borne diseases further around the world, collaborative investment is required to solve this issue.
Freeing up health data requires demonstrating to all stakeholders that information-sharing is in their interests and can be done in a trustworthy way.
The Centre for Health and Healthcare is identifying and scaling up solutions for more resilient, efficient, and equitable healthcare systems.
The Centre for Nature and Climate is accelerating net-zero climate action, regenerates food, water and ocean systems, and promotes circular economies.
The Centre for the Fourth Industrial Revolution is advancing the application of human-centred and society-serving technologies.
The Centre for the New Economy and Society is providing a platform for leaders to shape inclusive and equitable economies and societies that create opportunity for all.
